Pliant Therapeutics, Inc. (PLRX) vs RenovoRx, Inc. (RNXT)
A side-by-side comparison of Pliant Therapeutics, Inc. and RenovoRx, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PLRX
Pliant Therapeutics, Inc.
$1.02HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
RNXT
RenovoRx, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — PLRX vs RNXT
growth of $100 · dividends reinvested · last 5yPLRX -94.4% (-43.7%/yr)RNXT -79.8% (-27.3%/yr)RNXT compounded faster over this window
PLRX RNXT
PLRX vs RNXT: by the numbers
- •RNXT is the larger company ($64M vs $63M market cap).
- •Both run net losses; PLRX's is the smaller (0.00% vs -621.71% net margin).
Metrics side by side
Valuation
| Metric | PLRX | RNXT |
|---|---|---|
| P/S ratio | N/A | 32.49 |
| P/B ratio | 0.43 | 7.15 |
Profitability
| Metric | PLRX | RNXT |
|---|---|---|
| Gross margin | 0.00% | 70.88% |
| Operating margin | 0.00% | -1113.98% |
| Net margin | 0.00% | -621.71% |
| ROE | -62.81% | -136.82% |
| ROIC | -56.22% | -139.74% |
Growth (annualized)
| Metric | PLRX | RNXT |
|---|---|---|
| Total return CAGR (5Y) | -43.17% | -23.80% |
Frequently asked
- How have PLRX and RNXT total returns compared?
- Over the past 5 years, PLRX delivered -43.17% and RNXT delivered -23.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.